|
1
|
Fankhauser CD and Mostafid H: Prevention
of bladder cancer incidence and recurrence: Nutrition and
lifestyle. Curr Opin Urol. 28:88–92. 2018. View Article : Google Scholar
|
|
2
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar
|
|
3
|
Liu Z, Xie D and Zhang H: Long noncoding
RNA neuroblastoma-associated transcript 1 gene inhibits malignant
cellular phenotypes of bladder cancer through miR-21/SOCS6 axis.
Cell Death Dis. 9:10422018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heishima K, Meuten T, Yoshida K, Mori T
and Thamm DH: Prognostic significance of circulating microRNA-214
and-126 in dogs with appendicular osteosarcoma receiving amputation
and chemotherapy. BMC Vet Res. 15:392019. View Article : Google Scholar
|
|
5
|
Xue Y, Ge Y, Kang M, Wu C, Wang Y, Rong L
and Fang Y: Selection of three miRNA signatures with prognostic
value in non-M3 acute myeloid leukemia. BMC Cancer. 19:1092019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ribas J, Ni X, Castanares M, Liu MM, Esopi
D, Yegnasubramanian S, Rodriguez R, Mendell JT and Lupold SE: A
novel source for miR-21 expression through the alternative
polyadenylation of VMP1 gene transcripts. Nucleic Acids Res.
40:6821–6833. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ni K, Wang D, Xu H, Mei F, Wu C, Liu Z and
Zhou B: miR-21 promotes non-small cell lung cancer cells growth by
regulating fatty acid metabolism. Cancer Cell Int. 19:2192019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chai C, Song LJ, Han SY, Li XQ and Li M:
MicroRNA-21 promotes glioma cell proliferation and inhibits
senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT
signaling pathway. CNS Neurosci Ther. 24:369–380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Folini M, Gandellini P, Longoni N, Profumo
V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S,
Salvioni R, et al: miR-21: An oncomir on strike in prostate cancer.
Mol Cancer. 9:122010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiu YF, Wang MX, Meng LN, Zhang R and Wang
W: MiR-21 regulates proliferation and apoptosis of oral cancer
cells through TNF-α. Eur Rev Med Pharmacol Sci. 22:7735–7741.
2018.PubMed/NCBI
|
|
11
|
Badr M, Said H, Louka ML, Elghazaly HA,
Gaballah A and Atef Abd El Mageed M: MicroRNA-21 as a predictor and
prognostic factor for trastuzumab therapy in human epidermal growth
factor receptor 2-positive metastatic breast cancer. J Cell
Biochem. 120:3459–3466. 2019. View Article : Google Scholar
|
|
12
|
Hao JP and Ma A: The ratio of
miR-21/miR-24 as a promising diagnostic and poor prognosis
biomarker in colorectal cancer. Eur Rev Med Pharmacol Sci.
22:8649–8656. 2018.PubMed/NCBI
|
|
13
|
Zhang HH, Qi F, Cao YH, Zu XB and Chen MF:
Expression and clinical significance of microRNA-21, maspin and
vascular endothelial growth factor-C in bladder cancer. Oncol Lett.
10:2610–2616. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
He Y, Liu H, Jiang L, Rui B, Mei J and
Xiao H: miR-26 induces apoptosis and inhibits autophagy in
non-small cell lung cancer cells by suppressing TGF-β1-JNK
signaling pathway. Front Pharmacol. 9:15092019. View Article : Google Scholar
|
|
16
|
Iswariya GT, Paital B, Padma PR and
Nirmaladevi R: microRNAs: Epigenetic players in cancer and aging.
Front Biosci (Schol Ed). 11:29–55. 2019. View Article : Google Scholar
|
|
17
|
Kroemer G, Mariño G and Levine B:
Autophagy and the integrated stress response. Mol Cell. 40:280–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Menzies FM, Fleming A, Caricasole A, Bento
CF, Andrews SP, Ashkenazi A, Füllgrabe J, Jackson A, Jimenez
Sanchez M, Karabiyik C, et al: Autophagy and neurodegeneration:
Pathogenic mechanisms and therapeutic opportunities. Neuron.
93:1015–1034. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Monkkonen T and Debnath J: Inflammatory
signaling cascades and autophagy in cancer. Autophagy. 14:190–198.
2018. View Article : Google Scholar :
|
|
20
|
Kung CP, Budina A, Balaburski G,
Bergenstock MK and Murphy M: Autophagy in tumor suppression and
cancer therapy. Crit Rev Eukaryot Gene Expr. 21:71–100. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Amaravadi R, Kimmelman AC and White E:
Recent insights into the function of autophagy in cancer. Genes
Dev. 30:1913–1930. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia L, Huang S, Yin X, Zan Y, Guo Y and
Han L: Quercetin suppresses the mobility of breast cancer by
suppressing glycolysis through Akt-mTOR pathway mediated autophagy
induction. Life Sci. 208:123–130. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao GS, Gao ZR, Zhang Q, Tang XF, Lv YF,
Zhang ZS, Zhang Y, Tan QL, Peng DB, Jiang DM and Guo QN: TSSC3
promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR
pathway to suppress tumorigenesis and metastasis in osteosarcoma,
and predicts a favorable prognosis. J Exp Clin Cancer Res.
37:1882018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qie S and Diehl JA: Cyclin D1, cancer
progression, and opportunities in cancer treatment. J Mol Med
(Berl). 94:1313–1326. 2016. View Article : Google Scholar
|
|
26
|
Oh SJ, Cho H, Kim S, Noh KH, Song KH, Lee
HJ, Woo SR, Kim S, Choi CH, Chung JY, et al: Targeting cyclin
D-CDK4/6 sensitizes immune-refractory cancer by blocking the
SCP3-NANOG axis. Cancer Res. 78:2638–2653. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang R, Wang J, Dong T, Shen J, Gao X and
Zhou J: Naringenin has a chemoprotective effect in MDA-MB-231
breast cancer cells via inhibition of caspase-3 and -9 activities.
Oncol Lett. 17:1217–1222. 2019.PubMed/NCBI
|
|
28
|
Shalini S, Dorstyn L, Dawar S and Kumar S:
Old, new and emerging functions of caspases. Cell Death Differ.
22:526–539. 2015. View Article : Google Scholar :
|
|
29
|
Guo F, Liu J, Han X, Zhang X, Lin T, Wang
Y, Bai J and Han J: FBXO22 suppresses metastasis in human renal
cell carcinoma via inhibiting MMP-9-mediated migration and invasion
and VEGF-mediated angiogenesis. Int J Biol Sci. 15:647–656. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng X, Carstens JL, Kim J, Scheible M,
Kaye J, Sugimoto H, Wu CC, LeBleu VS and Kalluri R:
Epithelial-to-mesenchymal transition is dispensable for metastasis
but induces chemoresistance in pancreatic cancer. Nature.
527:525–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jie XX, Zhang XY and Xu CJ:
Epithelial-to-mesenchymal transition, circulating tumor cells and
cancer metastasis: Mechanisms and clinical applications.
Oncotarget. 8:81558–81571. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Catalano M, D'Alessandro G, Lepore F,
Corazzari M, Caldarola S, Valacca C, Faienza F, Esposito V,
Limatola C, Cecconi F and Di Bartolomeo S: Autophagy induction
impairs migration and invasion by reversing EMT in glioblastoma
cells. Mol Oncol. 9:1612–1625. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gugnoni M, Sancisi V, Manzotti G, Gandolfi
G and Ciarrocchi A: Autophagy and epithelial-mesenchymal
transition: An intricate interplay in cancer. Cell Death Dis.
7:e25202016. View Article : Google Scholar : PubMed/NCBI
|
